高盛发表研究报告指出,康龙化成(03759.HK) 与礼来(LLY.US) 达成合作协议,支持Orforglipron在中国的本地供应,礼来预期向康龙化成投资2亿美元,以支持其技术能力建设,并随着项目进展,有望进一步扩大合作范围。同时,礼来计划在未来十年累计投资30亿美元,与多家本地企业全面扩大其在中国的供应链产能,目标是为口服固体制剂建立本地化制造及供应体系,特别专注于建设...
Source Link高盛发表研究报告指出,康龙化成(03759.HK) 与礼来(LLY.US) 达成合作协议,支持Orforglipron在中国的本地供应,礼来预期向康龙化成投资2亿美元,以支持其技术能力建设,并随着项目进展,有望进一步扩大合作范围。同时,礼来计划在未来十年累计投资30亿美元,与多家本地企业全面扩大其在中国的供应链产能,目标是为口服固体制剂建立本地化制造及供应体系,特别专注于建设...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.